A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 100.35
GOOG 732.66
MSFT 52.32
FB 119.38
BAC 14.88

Recently Added

CIX 11.25
ZBH 123.07
PPCH 0.02
SPHS 0.99
GAIN 7.05

Gaining Speed

PPCH 0.02
SPHS 0.99
ZBH 123.07
GAIN 7.05
CIX 11.25

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!